Life Issues Institute Lauds Adult Stem Cell Funding

(Cincinnati, OH) May 25, 2005 – Life Issues Institute applauds the House approval of the Stem Cell Therapeutic and Research Act (HR 2520). This legislation, which passed by a vote of 431 to 1, proposed by Rep. Chris Smith (R-NJ), will create a new federally funded stem cell therapeutic and research program for the collection and inventory of umbilical cord blood. “We strongly support research and advances using adult stem cells. They have proven effective in treating over 58 diseases and conditions in humans. Importantly, they do not require the deaths of other human beings to further science,” said Bradley Mattes, Executive Director of Life Issues Institute. Lawmakers also pointed to the dozens of cures and treatments obtained from adult stem cells and the failure of embryonic stem cells to cure any patients.

The House also passed HR 810, 238 to 194, 50 votes short of a veto override. Life Issues Institute stands with President Bush in opposing HR 810, which would federally fund the killing of human embryos for research. President Bush has vowed to veto HR 810.

In addition, at the White House, President Bush spoke to a group that included 21 children who were adopted when they were still embryos. Bush said, “The children here today remind us that there is no such thing as a spare embryo. Every embryo is unique and genetically complete, like every other human being. And each of us started out our life this way. These lives are not raw material to be exploited, but gifts. And I commend each of the families here today for accepting the gift of these children and offering them the gift of your love.”

###

About Life Issues Institute: Life Issues Institute is dedicated to changing hearts and minds of millions of people through education. Organizations and individuals around the world depend upon Life Issues Institute to provide the latest information and effective tools to protect innocent human life from womb to tomb.

Life Issues Institute welcomes comments relevant to columns that are civil, concise, and respectful of other contributors. We do not publish comments with links to other websites or other online material.

Leave a Reply

Your email address will not be published.